These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


468 related items for PubMed ID: 16729901

  • 1. Vaccines for the prevention of human papillomavirus and associated gynecologic diseases: a review.
    Ault KA.
    Obstet Gynecol Surv; 2006 Jun; 61(6 Suppl 1):S26-31. PubMed ID: 16729901
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Human papillomavirus prophylactic vaccines: stakes and perspectives].
    Hantz S, Alain S, Denis F.
    Gynecol Obstet Fertil; 2006 Jun; 34(7-8):647-55. PubMed ID: 16807045
    [Abstract] [Full Text] [Related]

  • 4. Vaccines for preventing HPV-related anogenital infection and neoplasia.
    Ferris DG.
    J Am Osteopath Assoc; 2006 Mar; 106(3 Suppl 1):S9-13. PubMed ID: 16729555
    [Abstract] [Full Text] [Related]

  • 5. Cellular immune responses to human papillomavirus (HPV)-16 L1 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles.
    Pinto LA, Edwards J, Castle PE, Harro CD, Lowy DR, Schiller JT, Wallace D, Kopp W, Adelsberger JW, Baseler MW, Berzofsky JA, Hildesheim A.
    J Infect Dis; 2003 Jul 15; 188(2):327-38. PubMed ID: 12854090
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Strategies for the prevention of cervical cancer by human papillomavirus vaccination.
    Williamson AL, Passmore JA, Rybicki EP.
    Best Pract Res Clin Obstet Gynaecol; 2005 Aug 15; 19(4):531-44. PubMed ID: 16150392
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Decreasing risk: impact of HPV vaccination on outcomes.
    Hymel PA.
    Am J Manag Care; 2006 Dec 15; 12(17 Suppl):S473-83. PubMed ID: 17203991
    [Abstract] [Full Text] [Related]

  • 10. Immunobiology of human papillomavirus infection and vaccination - implications for second generation vaccines.
    Stanley M, Gissmann L, Nardelli-Haefliger D.
    Vaccine; 2008 Aug 19; 26 Suppl 10():K62-7. PubMed ID: 18847558
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Human papillomavirus vaccines].
    Brun JL.
    J Gynecol Obstet Biol Reprod (Paris); 2008 Feb 19; 37 Suppl 1():S155-66. PubMed ID: 18187268
    [Abstract] [Full Text] [Related]

  • 16. Immune control of human papillomavirus (HPV) associated anogenital disease and potential for vaccination.
    Stern PL.
    J Clin Virol; 2005 Mar 19; 32 Suppl 1():S72-81. PubMed ID: 15753015
    [Abstract] [Full Text] [Related]

  • 17. Vaccines against human papillomavirus and cervical cancer: promises and challenges.
    Mahdavi A, Monk BJ.
    Oncologist; 2005 Aug 19; 10(7):528-38. PubMed ID: 16079320
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 24.